Patients who underwent a stem cell transplant and received the Triplex vaccine to prevent a type of herpes virus – cytomegalovirus (CMV) – from duplicating out of control were 50% less likely...

The U.S. Food and Drug Administration (FDA) on Thursday approved Merck’s PREVYMIS™ (letermovir) once-daily tablets for oral use and injection for intravenous infusion. PREVYMIS is indicated for...